| Tap a line for its trend | Currentlast close | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 |
|---|
| 1,780 | — | — | — | |
| 1.9 | 1.9 | — | — | |
| 26.8 | 26.8 | 22.1 | 22.4 | |
| 1,804 | — | — | — | |
| 148 | 148 | 154 | 140 | |
| — | −3.7% | +10.1% | — | |
| 2.3 | 2.3 | 3.0 | −2.7 | |
| 1.6% | 1.6% | 2.0% | −1.9% | |
| 2.3 | 2.3 | 3.0 | −2.7 | |
| 2.1 | 2.1 | 0.9 | −5.3 | |
| 1.4% | 1.4% | 0.6% | −3.8% | |
| ₹0.77 | ₹0.77 | ₹0.33 | −₹1.90 | |
| — | +131.5% | +117.5% | — | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current last close | |
|---|---|---|---|---|---|
| Market Capitalization | — | — | — | 1,779.5 | |
| - Cash, Equiv & ST Investments | — | — | 1.9 | 1.9 | |
| + Total Debt | 22.4 | 22.1 | 26.8 | 26.8 | |
| Enterprise Value | — | — | — | 1,804.4 | |
| Revenue | 139.5 | 153.7 | 148.0 | 148.0 | |
| Growth %, YoY | — | +10.1 | -3.7 | — | |
| EBITDA | -2.7 | 3.0 | 2.3 | 2.3 | |
| Margin % | -1.90 | 1.96 | 1.55 | 1.55 | |
| EBIT | -2.7 | 3.0 | 2.3 | 2.3 | |
| Net Income | -5.3 | 0.9 | 2.1 | 2.1 | |
| Margin % | -3.77 | 0.60 | 1.44 | 1.44 | |
| EPS, Adj (current shares) | -1.90 | 0.33 | 0.77 | 0.77 | |
| Growth %, YoY | — | +117.5 | +131.5 | — | |
Figures from the company's filings with NSE
In FY26 its consolidated net profit was ₹2.1 crore on revenue of ₹148 crore. Its debt-to-equity ratio was 0.48 on 31 March 2026.
No. Indokem had borrowings of ₹26.8 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.48. Its cash and current investments were ₹1.9 crore, so its net debt was ₹24.9 crore.
Indokem's debt-to-equity ratio was 0.48 on 31 March 2026: borrowings of ₹26.8 crore against total equity of ₹55.3 crore.
In FY26, Indokem earned net profit of ₹2.1 crore on revenue of ₹148 crore, against ₹4.5 crore on ₹84.9 crore for Amal. Indokem's operating margin was 1.5% (Amal 7.5%) and its return on equity 3.9% (Amal 4.6%).
Indokem's net worth — shareholders' equity in its consolidated balance sheet — was ₹55.3 crore on 31 March 2026.
Indokem's book value per share was ₹19.99 on 31 March 2026: shareholders' equity of ₹55.3 crore divided by the 2.77 crore shares in issue.
Indokem's basic earnings per share (EPS) were ₹0.77 in FY26, against ₹0.33 in FY25.
In FY26, Indokem's return on equity (ROE) was 3.9% and its return on capital employed (ROCE) was 2.9%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 1.7% and ROCE 4.2%.
In FY26 (April 2025–March 2026), Indokem's consolidated net profit was ₹2.1 crore, up 131.5% from ₹92 lakh in FY25, on revenue from operations of ₹148 crore (down 3.7%). Over three years, from FY22, net profit was down 24.7%.
On FY26 consolidated figures, against Amal and Chemcrux Enterprises: Indokem's operating margin of 1.5% is the lowest of the three (Amal 7.5%, Chemcrux Enterprises 6.6%; peer average 7.0%); its revenue growth over three years of 9.2% a year is the second highest of the three (Amal 29.4% a year, Chemcrux Enterprises −4.6% a year; peer average 12.4% a year).
From Indokem's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
